Search for: "Amneal Pharmaceuticals LLC" Results 21 - 40 of 42
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Apr 2017, 9:58 pm by Patent Docs
., Amneal Pharmaceuticals LLC, Amneal... [read post]
8 Sep 2014, 8:59 pm by Patent Docs
Amneal Pharmaceuticals, LLC 2:14-cv-05420; filed August 28, 2014 in the District Court of New Jersey The complaints in these cases are substantially identical. [read post]
12 Sep 2018, 9:46 am by Eric Caligiuri
This case was originally filed in March 2016 by Galderma against Amneal Pharmaceuticals under the HatchWaxman Act, 35 U.S.C. [read post]
17 Jul 2014, 10:58 am
USA; Accord Healthcare, Inc.; Intas Pharmaceuticals Ltd.; Amneal Pharmaceuticals LLC; Amneal Pharmaceuticals of New York, LLC; Amneal Pharmaceuticals Co. [read post]
17 Mar 2014, 11:03 am
.; Intas Pharmaceuticals Ltd.; Amneal Pharmaceuticals LLC; Amneal Pharmaceuticals of New York, LLC; Amneal Pharmaceuticals Co. [read post]
30 Jun 2014, 10:28 am
USA; Accord Healthcare, Inc.; Intas Pharmaceuticals Ltd.; Amneal Pharmaceuticals LLC; Amneal Pharmaceuticals of New York, LLC; Amneal Pharmaceuticals Co. [read post]
2 Jan 2014, 1:12 pm by Gene Quinn
” The judgment removes a major hurdle for Amneal Pharmaceuticals LLC, a U.S. [read post]
27 Dec 2012, 3:47 pm by Bexis
Amneal Pharmaceuticals, LLC, 2012 WL 2990697, at *8-9 (E.D. [read post]
24 Jun 2014, 2:14 pm by FDABlog HPM
  Earlier this week, generic drug manufacturers Amneal Pharmaceuticals, LLC, Par Pharmaceutical, Inc., and Roxane Laboratories, Inc. submitted a Petition to the PTAB challenging U.S. [read post]
14 Oct 2019, 10:36 am by Renae Lloyd
As of last Tuesday, the biggest losers, included energy, healthcare and communications companies, according to Bloomberg: Amneal Pharmaceuticals LLC (AMRX CUSIP: 03168L105)  – $2.7 billion loan due 2025 has sunk to about 80 cents on the dollar, Seadrill Operating LP (SDRL CUSIP: G7998G106) – $2.6 billion loan maturing in 2021 fetches around 53 cents. [read post]
1 Feb 2016, 10:43 am by Lawrence B. Ebert
’” Greenliant Sys., Inc. v.Xicor LLC, 692 F.3d 1261, 1268 (Fed. [read post]